Literature DB >> 14642446

Hyperglycolysis is exacerbated after traumatic brain injury with fentanyl vs. isoflurane anesthesia in rats.

Kimberly D Statler1, Keri L Janesko, John A Melick, Robert S B Clark, Larry W Jenkins, Patrick M Kochanek.   

Abstract

Despite common use of narcotics in the clinical management of severe traumatic brain injury (TBI), in experimental models rats treated with fentanyl have exhibited worse functional outcome and more CA1 hippocampal death than rats treated with standard isoflurane anesthesia. We hypothesized that greater post-traumatic excitotoxicity, reflected by cerebral glucose utilization (CMRglu), may account for detrimental effects of fentanyl vs. isoflurane. Rats were anesthetized with either isoflurane (1% by inhalation) or fentanyl (10 mcg/kg iv bolus then 50 mcg/kg/h infusion). 14C-deoxyglucose autoradiography was performed 45 min after controlled cortical impact (CCI) to left parietal cortex (n=4 per anesthetic group) or in uninjured rats after 45 min of anesthesia (n=3 per anesthetic group). Uninjured rats treated with fentanyl vs. isoflurane showed 35-45% higher CMRglu in all brain structures (p<0.05) except CA3. After TBI in rats treated with isoflurane, CMRglu increased significantly only in ipsilateral CA1 and ipsilateral parietal cortex (p<0.05 vs. isoflurane uninjured). Conversely, after TBI in rats treated with fentanyl, CMRglu increased markedly and bilaterally in CA1 and CA3 (p<0.05 vs. fentanyl uninjured), but not ipsilateral parietal cortex. In contralateral CA1, CMRglu was nearly two times greater after TBI in fentanyl vs. isoflurane treated rats (p<0.05). Hyperglycolysis was exacerbated in CA1 and CA3 hippocampus after TBI in rats treated with fentanyl vs. isoflurane anesthesia. This post-traumatic hyperglycolysis suggests greater excitotoxicity and concurs with reports of worse functional outcome and more CA1 hippocampal death after TBI with fentanyl vs. isoflurane anesthesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642446     DOI: 10.1016/j.brainres.2003.09.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  A review of perioperative glucose control in the neurosurgical population.

Authors:  Joshua H Atkins; David S Smith
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

2.  Energy metabolic changes in the early post-injury period following traumatic brain injury in rats.

Authors:  Niklas Marklund; Konstantin Salci; Gunnar Ronquist; Lars Hillered
Journal:  Neurochem Res       Date:  2006-08-15       Impact factor: 3.996

3.  Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes.

Authors:  Katsunori Shijo; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2015-04-21       Impact factor: 3.252

4.  Hemorrhagic shock after experimental traumatic brain injury in mice: effect on neuronal death.

Authors:  Alia Marie Dennis; M Lee Haselkorn; Vincent A Vagni; Robert H Garman; Keri Janesko-Feldman; Hülya Bayir; Robert S B Clark; Larry W Jenkins; C Edward Dixon; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2009-06       Impact factor: 5.269

Review 5.  Using anesthetics and analgesics in experimental traumatic brain injury.

Authors:  Rachel K Rowe; Jordan L Harrison; Theresa C Thomas; James R Pauly; P David Adelson; Jonathan Lifshitz
Journal:  Lab Anim (NY)       Date:  2013-08       Impact factor: 12.625

Review 6.  Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury.

Authors:  André Mendes Arent; Luiz Felipe de Souza; Roger Walz; Alcir Luiz Dafre
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

Review 7.  Roadmap for Advancing Pre-Clinical Science in Traumatic Brain Injury.

Authors:  Douglas H Smith; Patrick M Kochanek; Susanna Rosi; Retsina Meyer; Chantelle Ferland-Beckham; Eric M Prager; Stephen T Ahlers; Fiona Crawford
Journal:  J Neurotrauma       Date:  2021-08-13       Impact factor: 4.869

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.